Paul Dew, DO | |
1010 Carondelet Dr, Ste 220, Kansas City, MO 64114-4859 | |
(816) 941-1600 | |
(816) 941-1699 |
Full Name | Paul Dew |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine |
Location | 1010 Carondelet Dr, Kansas City, Missouri |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679528673 | NPI | - | NPPES |
42969014 | Other | MO | BLUECROSS BLUESHIELD OF KC |
7798562 | Other | MO | CIGNA HEALTHCARE OF KANSAS/MISSOURI, INC |
7798562 | Other | MO | AETNA US HEALTHCARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083P0500X | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine | 2000162374 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Paul Dew, DO 1010 Carondelet Dr, Ste 220, Kansas City, MO 64114-4859 Ph: (816) 941-1600 | Paul Dew, DO 1010 Carondelet Dr, Ste 220, Kansas City, MO 64114-4859 Ph: (816) 941-1600 |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that it has delivered a written response to the request for proposal (RFP) announced on September 21, 2009 from the U.S. Department of Health & Human Services (HHS) for the supply of intravenous (i.v) peramivir for the treatment of critically ill influenza patients under Emergency Use Authorization (EUA). BioCryst management intends to provide an update once the RFP process has reached a conclusion.
Young males who have been sexually abused are five times more likely to cause teen pregnancy compared to those with no abuse history, according to University of British Columbia research. Sexually abused boys are also three times more likely to have multiple sexual partners and twice as likely to engage in unprotected sex.
Today, MedImmune announced that researchers will present data from its oncology portfolio, including new clinical data, at two upcoming medical congresses in Europe and the United States.
Slate examines a new rapid diagnostic test and an experimental vaccine for leprosy, both developed by the Infectious Disease Research Institute in Seattle, writing, "The two tools together could finally free humans from the vicious cycle of a disease that has afflicted the population for at least 4,000 years."
› Verified 8 days ago
Craig S Lofgreen, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 720 Oak St, Kansas City, MO 64106 Phone: 615-778-4066 | |
Bipinchandra Avashia, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 6401 E Front St, Kansas City, MO 64120 Phone: 816-241-0603 Fax: 816-241-6276 | |
Scott R Steelman, D.O. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 9151 Ne 81st Ter, Kansas City, MO 64158 Phone: 816-407-2300 | |
Robert T Tenny, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 4320 Wornall Rd, Suite 432, Kansas City, MO 64111 Phone: 816-560-0555 Fax: 816-268-4740 | |
Michael Laird Bledsoe, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 8880 Ne 82nd Terrace, Mosaic Life Care, Kansas City, MO 64158 Phone: 816-437-8171 Fax: 816-407-9603 | |
Dr. Larry Flick Wilson, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Faa, Ace-300, 901 Locust Street, Rm 350, Kansas City, MO 64106 Phone: 816-329-3250 |